Mismatch negativity in bipolar disorder: A neurophysiological biomarker of intermediate effect?
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 191, 132-139
Abstract
No abstract availableKeywords
Funding Information
- National Health & Medical Research Council (APP1061043)
- NHMRC early career fellowship (APP1122362, APP1112611)
This publication has 79 references indexed in Scilit:
- RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patientsJournal of Affective Disorders, 2012
- MMN/P3a deficits in first episode psychosis: Comparing schizophrenia-spectrum and affective-spectrum subgroupsSchizophrenia Research, 2011
- Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey InitiativeArchives of General Psychiatry, 2011
- Impaired MMN/P3a complex in first-episode psychosis: Cognitive and psychosocial associationsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2010
- Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patientsMolecular Psychiatry, 2009
- The mismatch negativity: A review of underlying mechanismsClinical Neurophysiology, 2009
- Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosisPsychopharmacology, 2008
- The mismatch negativity (MMN) in basic research of central auditory processing: A reviewClinical Neurophysiology, 2007
- Progressive and Interrelated Functional and Structural Evidence of Post-Onset Brain Reduction in SchizophreniaArchives of General Psychiatry, 2007
- Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorderBrain Research, 2007